Verition Fund Management’s Somnigroup International SGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,600
Closed -$500K 3764
2025
Q4
$500K Sell
5,600
-12,000
-68% -$1.05M ﹤0.01% 2656
2025
Q3
$1.48M Hold
17,600
0.01% 2221
2025
Q2
$1.2M Hold
17,600
0.01% 2340
2025
Q1
$1.05M Sell
17,600
-12,400
-41% -$750K ﹤0.01% 2091
2024
Q4
$1.7M Sell
30,000
-5,600
-16% -$299K 0.01% 1661
2024
Q3
$1.94M Hold
35,600
0.01% 1432
2024
Q2
$1.69M Buy
35,600
+1,700
+5% +$86.1K 0.01% 1365
2024
Q1
$1.93M Buy
+33,900
New +$1.77M 0.01% 1234
2022
Q4
Sell
-9,600
Closed -$232K 2871
2022
Q3
$232K Buy
+9,600
New +$249K ﹤0.01% 2408
2022
Q2
Sell
-21,300
Closed -$594K 3175
2022
Q1
$594K Buy
21,300
+14,900
+233% +$549K 0.01% 1815
2021
Q4
$301K Buy
+6,400
New +$290K ﹤0.01% 1987

Other funds holding SGI

Verition Fund Management's SGI Position: Q1 2026 in Review

Verition Fund Management reduced its Somnigroup International (SGI) stake by 64% in Q1 2026, selling an estimated $6.63M and leaving 42,143 shares worth $3.12M. The position accounts for 0.02% of the portfolio, ranked #779.

Verition Fund Management first reported a position in SGI in Q4 2013 and has held it in 32 quarters since. The position peaked at $25.1M in Q4 2024. 523 funds tracked by Wall St. Rank hold SGI as of Q1 2026.

  • Verition Fund Management held 42,143 shares of Somnigroup International worth $3.12M as of Q1 2026.
  • Verition Fund Management sold 76,387 Somnigroup International shares in Q1 2026, an estimated $6.63M.
  • Somnigroup International made up 0.02% of Verition Fund Management's portfolio in Q1 2026, its #779 holding.
  • Verition Fund Management first reported a position in Somnigroup International in Q4 2013 and has held it in 32 quarters since.
  • Verition Fund Management's Somnigroup International position peaked at $25.1M in Q4 2024.
  • 523 funds tracked by Wall St. Rank held Somnigroup International as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.